Related News
July
17,
2026
Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network
July
16,
2026
Construction work is part of Destination: Grand campus expansion project transforming Henry Ford Hospital in Detroit.
July
14,
2026
Patients at Henry Ford Health have access to the Sonata System, a minimally invasive incisionless alternative for managing fibroids and their symptoms.
July
13,
2026
New service will help safely move seriously ill babies and children to specialized pediatric care at Henry Ford St. John Children’s Hospital.
July
10,
2026
This marks the second ULP charge filed by the union related to the ongoing labor dispute that has been dismissed. A third charge was withdrawn, as well as large portions of a fourth charge.
July
7,
2026
Two new studies found 80-90% improvement in health outcomes and $9,000 per patient savings on average for Health Alliance Plan Medicare Advantage members
July
6,
2026
Recognition highlights Henry Ford Health’s support for newly licensed nurses across southeast Michigan
June
25,
2026
Downriver hospital marks century of compassionate care with celebration honoring the past and looking to the future.
June
17,
2026
Henry Ford Hospital brought together nurses from across the organization on June 1 for its 18th annual conference in Detroit. This year’s theme, “The Future of Nursing: Discovery, Innovation, Impact,” highlighted the system’s continued investment in empowering nurses through research, evidence-based practice and quality improvement.
June
12,
2026
After surviving heart failure, three doctors in training are turning lived experience into patient care
Media Briefing on Moderna Vaccine Trial
November
16,
2020

Henry Ford Health System discussed its role in the Moderna vaccine trial after the drugmaker announced today that early data from its mRNA trial showed its vaccine is 94.5% effective. Henry Ford was the only hospital in Michigan and one of about 90 nationally chosen to participate in the trial. Henry Ford was a key site for enrolling minority volunteers who were hardest hit by COVID-19.
Leading the media briefing are Paul Kilgore, M.D., MPH, a Henry Ford co-principal investigator in the vaccine trial, and Kellie McFarlin, M.D., a Henry Ford general surgeon and a volunteer vaccine participant. They were joined by Melanie Ivarsson, Ph.D., chief development officer for Moderna.